| 000 | 01008 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514014729.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(01)06427-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlackman, B T | |
| 245 | 0 | 0 |
_aCocaine use and acute coronary syndromes. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 2001 |
||
| 300 |
_a1367; author reply 1367-8 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aCocaine _xpoisoning |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetoprolol _xadverse effects |
| 650 | 0 | 4 |
_aMyocardial Infarction _xchemically induced |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 773 | 0 |
_tLancet (London, England) _gvol. 358 _gno. 9290 _gp. 1367; author reply 1367-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(01)06427-3 _zAvailable from publisher's website |
| 999 |
_c11601116 _d11601116 |
||